scispace - formally typeset
T

Tim Luckett

Researcher at University of Technology, Sydney

Publications -  150
Citations -  3971

Tim Luckett is an academic researcher from University of Technology, Sydney. The author has contributed to research in topics: Palliative care & Medicine. The author has an hindex of 31, co-authored 130 publications receiving 3146 citations. Previous affiliations of Tim Luckett include University of New South Wales & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations

TL;DR: Choice should be guided by the availability, content, scale structure and psychometric properties of relevant European Organisation for the Research and Treatment of Cancer versus Functional Assessment of Chronic Illness Therapy modules.
Journal ArticleDOI

Review of Adherence-Related Issues in Adolescents and Young Adults With Cancer

TL;DR: Overall, the evidence base for adherence and strategies to promote it in AYAs with cancer is woefully lacking and there is a need for high-quality studies that target clinically important questions, randomized controlled trials of theoretically based interventions, and development and evaluation of training programs for oncology staff in the special issues faced by AY as with cancer.
Journal ArticleDOI

Dying in the hospital setting: A systematic review of quantitative studies identifying the elements of end-of-life care that patients and their families rank as being most important

TL;DR: This review adds to what has been known for over two decades in relation to patient and family priorities for end-of-life care within the hospital setting, namely, effective communication and shared decision making, expert care, respectful and compassionate care and trust and confidence in clinicians.
Journal ArticleDOI

Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis.

TL;DR: Hispanic cancer patients in the USA, but not other ethnic minority groups, report significantly worse distress, depression, social HRZoL, and overall HRQoL than do majority patients, of which all but depression might be clinically important.